Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC

Oncogene, Published online: 31 July 2023; doi:10.1038/s41388-023-02790-8Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC

Source: Oncogene - July 31, 2023 Category: Cancer & Oncology Authors: Boya Zhang Mingpeng Zhang Yanjie Yang Qi Li Jianpeng Yu Shimiao Zhu Yuanjie Niu Zhiqun Shang Source Type: research